Stock listing
Estrella Immunopharma, Inc.
Selected listing: ESLA · NASDAQ · USD · US
Estrella Immunopharma, Inc. (NASDAQ:ESLA), Health Technology. Latest release Aug 3, 2026: Estrella Immunopharma Activates Oregon Health & Science University…
- Ticker
- NASDAQ:ESLA
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Estrella Immunopharma, Inc.
The company focuses on developing innovative immunotherapy solutions. As a publicly traded entity, Estrella Immunopharma is positioned within the American market, contributing to advancements in healthcare.
Latest news from Estrella Immunopharma, Inc.
Estrella Immunopharma Activates Oregon Health & Science University as Third Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma
August 3, 2026
Estrella Immunopharma Activates Baylor Scott & White Research Institute as Second Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma
July 29, 2026
Estrella Immunopharma Announces First Patient Dosed in Dose-Expansion Phase of STARLIGHT-1 Trial and Reports Durable Response Rate in Advanced B-Cell Non-Hodgkin’s Lymphoma
July 24, 2026
Estrella Immunopharma to Participate in the D. Boral Capital Global Conference
May 5, 2026
Estrella Immunopharma, Inc. (NASDAQ: ESLA) Receives Initiating Coverage with a Valuation of $12.00/Share from Zacks Small-Cap Research
March 22, 2026
Research Estrella Immunopharma, Inc.
Estrella Immunopharma, Inc. company profile
View the public company page for Estrella Immunopharma, Inc. on 6ix.
Estrella Immunopharma, Inc. news
Read company news and market updates connected to Estrella Immunopharma, Inc..
Estrella Immunopharma, Inc. investor events
Find investor webinars, events, and replay context for Estrella Immunopharma, Inc..